159 related articles for article (PubMed ID: 20531984)
21. Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.
Ferrand N; Stragier E; Redeuilh G; Sabbah M
Biochem J; 2012 Oct; 447(1):71-9. PubMed ID: 22765757
[TBL] [Abstract][Full Text] [Related]
22. The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells.
Mason HR; Lake AC; Wubben JE; Nowak RA; Castellot JJ
Mol Hum Reprod; 2004 Mar; 10(3):181-7. PubMed ID: 14981145
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
24. Temperal and spatial expression of CCN1, CCN3, CCN4, CCN5 and CCN6 proteins in the developing postnatal teeth.
Li S; Li S
J Cell Commun Signal; 2023 Jun; 17(2):275-285. PubMed ID: 37160590
[TBL] [Abstract][Full Text] [Related]
25. CCN5 Expression in mammals. III. Early embryonic mouse development.
Myers RB; Rwayitare K; Richey L; Lem J; Castellot JJ
J Cell Commun Signal; 2012 Dec; 6(4):217-23. PubMed ID: 22926930
[TBL] [Abstract][Full Text] [Related]
26. CCN5 modulates the antiproliferative effect of heparin and regulates cell motility in vascular smooth muscle cells.
Lake AC; Castellot JJ
Cell Commun Signal; 2003 Nov; 1(1):5. PubMed ID: 14636425
[TBL] [Abstract][Full Text] [Related]
27. Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.
Dhar G; Mehta S; Banerjee S; Gardner A; McCarty BM; Mathur SC; Campbell DR; Kambhampati S; Banerjee SK
Cancer Lett; 2007 Aug; 254(1):63-70. PubMed ID: 17383817
[TBL] [Abstract][Full Text] [Related]
28. Role of CCN, a vertebrate specific gene family, in development.
Katsube K; Sakamoto K; Tamamura Y; Yamaguchi A
Dev Growth Differ; 2009 Jan; 51(1):55-67. PubMed ID: 19128405
[TBL] [Abstract][Full Text] [Related]
29. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
30. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
Yoon PO; Lee MA; Cha H; Jeong MH; Kim J; Jang SP; Choi BY; Jeong D; Yang DK; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2010 Aug; 49(2):294-303. PubMed ID: 20430035
[TBL] [Abstract][Full Text] [Related]
31. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
[TBL] [Abstract][Full Text] [Related]
32. IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin.
Chowdhury S; Wang X; Srikant CB; Li Q; Fu M; Gong YJ; Ning G; Liu JL
Endocrinology; 2014 May; 155(5):1629-42. PubMed ID: 24552398
[TBL] [Abstract][Full Text] [Related]
33. CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway.
Sabbah M; Prunier C; Ferrand N; Megalophonos V; Lambein K; De Wever O; Nazaret N; Lachuer J; Dumont S; Redeuilh G
Mol Cell Biol; 2011 Apr; 31(7):1459-69. PubMed ID: 21262769
[TBL] [Abstract][Full Text] [Related]
34. CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.
Banerjee S; Dhar G; Haque I; Kambhampati S; Mehta S; Sengupta K; Tawfik O; Phillips TA; Banerjee SK
Cancer Res; 2008 Sep; 68(18):7606-12. PubMed ID: 18794149
[TBL] [Abstract][Full Text] [Related]
35. Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells.
Haque I; Banerjee S; Mehta S; De A; Majumder M; Mayo MS; Kambhampati S; Campbell DR; Banerjee SK
J Biol Chem; 2011 Dec; 286(50):43475-85. PubMed ID: 22020939
[TBL] [Abstract][Full Text] [Related]
36. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.
Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P
Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787
[TBL] [Abstract][Full Text] [Related]
37. Proposal for a unified CCN nomenclature.
Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
[TBL] [Abstract][Full Text] [Related]
38. Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.
Das A; Dhar K; Maity G; Sarkar S; Ghosh A; Haque I; Dhar G; Banerjee S; Banerjee SK
Sci Rep; 2017 Apr; 7(1):1220. PubMed ID: 28450698
[TBL] [Abstract][Full Text] [Related]
39. Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2.
Leask A
J Cell Commun Signal; 2010 Oct; 4(3):155-6. PubMed ID: 21063505
[TBL] [Abstract][Full Text] [Related]
40. Wisp2/CCN5 up-regulated in the central nervous system of GM3-only mice facilitates neurite formation in Neuro2a cells via integrin-Akt signaling.
Ohkawa Y; Ohmi Y; Tajima O; Yamauchi Y; Furukawa K; Furukawa K
Biochem Biophys Res Commun; 2011 Aug; 411(3):483-9. PubMed ID: 21723256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
